These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

522 related items for PubMed ID: 18316823

  • 1. Clinical outcomes after multilesion percutaneous coronary intervention: comparison between exclusive and selective use of drug-eluting stents.
    Bertrand OF, Faurie B, Larose E, Nguyen CM, Gleeton O, Déry JP, Noël B, Proulx G, Roy L, Costerousse O, De Larochellière R, Rodés-Cabau J.
    J Invasive Cardiol; 2008 Mar; 20(3):99-104. PubMed ID: 18316823
    [Abstract] [Full Text] [Related]

  • 2. Long-term safety and efficacy of drug-eluting stents: two-year results of the REAL (REgistro AngiopLastiche dell'Emilia Romagna) multicenter registry.
    Marzocchi A, Saia F, Piovaccari G, Manari A, Aurier E, Benassi A, Cremonesi A, Percoco G, Varani E, Magnavacchi P, Guastaroba P, Grilli R, Maresta A.
    Circulation; 2007 Jun 26; 115(25):3181-8. PubMed ID: 17562952
    [Abstract] [Full Text] [Related]

  • 3. Randomized comparison of everolimus-eluting and paclitaxel-eluting stents: two-year clinical follow-up from the Clinical Evaluation of the Xience V Everolimus Eluting Coronary Stent System in the Treatment of Patients with de novo Native Coronary Artery Lesions (SPIRIT) III trial.
    Stone GW, Midei M, Newman W, Sanz M, Hermiller JB, Williams J, Farhat N, Caputo R, Xenopoulos N, Applegate R, Gordon P, White RM, Sudhir K, Cutlip DE, Petersen JL, SPIRIT III Investigators.
    Circulation; 2009 Feb 10; 119(5):680-6. PubMed ID: 19171853
    [Abstract] [Full Text] [Related]

  • 4. Clinical outcomes following drug-eluting versus bare metal stent implantation for lesion subsets excluded from pivotal clinical trials: findings from the GHOST Study (Guthrie Health System Off-Label StenT Study).
    Harjai KJ, Orshaw P, Shenoy C, Acharji S, Sporn D, Aboufares A, Stapleton D.
    J Interv Cardiol; 2008 Aug 10; 21(4):315-24. PubMed ID: 18754967
    [Abstract] [Full Text] [Related]

  • 5. Comparison of outcomes of drug-eluting stents versus bare-metal stents in nonostial proximal left anterior descending coronary arteries.
    Bonello L, De Labriolle A, Lemesle G, Roy P, Steinberg DH, Slottow TL, Xue Z, Torguson R, Kaneshige K, Suddath WO, Satler LF, Kent KM, Lindsay J, Pichard AD, Waksman R.
    Am J Cardiol; 2009 Feb 15; 103(4):496-500. PubMed ID: 19195509
    [Abstract] [Full Text] [Related]

  • 6. Long-term follow-up of drug-eluting stents when inserted for on- and off-label indications.
    Qasim A, Cosgrave J, Latib A, Colombo A.
    Am J Cardiol; 2007 Dec 01; 100(11):1619-24. PubMed ID: 18036358
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Outcome differences with the use of drug-eluting stents for the treatment of in-stent restenosis of bare-metal stents versus drug-eluting stents.
    Steinberg DH, Gaglia MA, Pinto Slottow TL, Roy P, Bonello L, De Labriolle A, Lemesle G, Torguson R, Kineshige K, Xue Z, Suddath WO, Kent KM, Satler LF, Pichard AD, Lindsay J, Waksman R.
    Am J Cardiol; 2009 Feb 15; 103(4):491-5. PubMed ID: 19195508
    [Abstract] [Full Text] [Related]

  • 12. What is the risk of stent thrombosis associated with the use of paclitaxel-eluting stents for percutaneous coronary intervention?: a meta-analysis.
    Bavry AA, Kumbhani DJ, Helton TJ, Bhatt DL.
    J Am Coll Cardiol; 2005 Mar 15; 45(6):941-6. PubMed ID: 15766833
    [Abstract] [Full Text] [Related]

  • 13. Two-year clinical outcome after successful implantation of drug-eluting and bare metal stents in diabetic patients: results from a real-world single center registry.
    Dou KF, Xu B, Yang YJ, Chen JL, Qiao SB, Li JJ, Qin XW, Liu HB, Wu YJ, Chen J, Yao M, You SJ, Yuan JQ, Dai J, Gao RL.
    Chin Med J (Engl); 2009 Mar 20; 122(6):612-6. PubMed ID: 19323921
    [Abstract] [Full Text] [Related]

  • 14. Unrestricted use of drug-eluting stents compared with bare-metal stents in routine clinical practice: findings from the National Heart, Lung, and Blood Institute Dynamic Registry.
    Abbott JD, Voss MR, Nakamura M, Cohen HA, Selzer F, Kip KE, Vlachos HA, Wilensky RL, Williams DO.
    J Am Coll Cardiol; 2007 Nov 20; 50(21):2029-36. PubMed ID: 18021868
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Paclitaxel- versus sirolimus-eluting stents for unprotected left main coronary artery disease.
    Mehilli J, Kastrati A, Byrne RA, Bruskina O, Iijima R, Schulz S, Pache J, Seyfarth M, Massberg S, Laugwitz KL, Dirschinger J, Schömig A, LEFT-MAIN Intracoronary Stenting and Angiographic Results: Drug-Eluting Stents for Unprotected Coronary Left Main Lesions Study Investigators.
    J Am Coll Cardiol; 2009 May 12; 53(19):1760-8. PubMed ID: 19422982
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Clinical outcomes after sirolimus-eluting, paclitaxel-eluting, and bare metal stents (from the first phase of the prospective multicenter German DES.DE Registry).
    Nienaber CA, Akin I, Schneider S, Senges J, Fetsch T, Tebbe U, Willich SN, Stumpf J, Sabin GV, Silber S, Richardt G, Kuck KH, DES.DE Study Group.
    Am J Cardiol; 2009 Nov 15; 104(10):1362-9. PubMed ID: 19892051
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.